In its official comments, BIO notes that the key drivers of successful growth in our bio-based economy are:
Robust funding of public- and private-sector scientific research;
Strong and predictable intellectual property rights, with a flexible and well-functioning technology transfer system;
A dynamic capital investment environment, with competitive returns on investment capital;
Science- and risk-based regulation of biotechnology innovation that speeds the path to market and minimizes post-approval obstacles to commercialization and adoption;
Market-based incentives for the sale of biotechnology products that promote patient and consumer access and continued innovation; and
Public support that embraces the positive influence of biotechnology.
